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Abstract
Foot-and-mouth disease virus (FMDV) represses host translation machinery, blocks protein secretion, and cleaves
cellular proteins associated with signal transduction and the innate immune response to infection. Non-structural
proteins (NSPs) and non-coding elements (NCEs) of FMDV play a critical role in these biological processes. The
FMDV virion consists of capsid and nucleic acid. The virus genome is a positive single stranded RNA and encodes a
single long open reading frame (ORF) flanked by a long structured 5ʹ-untranslated region (5ʹ-UTR) and a short
3ʹ-UTR. The ORF is translated into a polypeptide chain and processed into four structural proteins (VP1, VP2, VP3,
and VP4), 10 NSPs (Lpro, 2A, 2B, 2C, 3A, 3B1–3, 3C
pro, and 3Dpol), and some cleavage intermediates. In the past
decade, an increasing number of studies have begun to focus on the molecular pathogenesis of FMDV NSPs and
NCEs. This review collected recent research progress on the biological functions of these NSPs and NCEs on the
replication and host cellular regulation of FMDV to understand the molecular mechanism of host–FMDV
interactions and provide perspectives for antiviral strategy and development of novel vaccines.
Background
Foot-and-mouth disease (FMD), an acute highly conta-
gious viral disease in susceptible cloven-hoofed animals,
was described 100 years ago. The etiologic agent, FMD
virus (FMDV), is a positive-sense, single-stranded RNA
virus that belongs to the Aphthovirus genus, Picornaviri-
dae family. FMDV is one of the most contagious viruses
in cloven-hoofed animals and can cause both acute and
prolonged, asymptomatic but persistent infection [1].
Upon infection of susceptible species, FMDV proliferates
rapidly and causes vesicular disease in feet and mouth.
The RNA virus genome of FMDV displays a very high
mutation rate because the virus-encoded RNA polymer-
ase lacks a proofreading mechanism [2, 3]. The high mu-
tation rate of FMDV, coupled with its rapid proliferation
and extensive population, result in the rapid evolution of
this virus [4], which contributes to the existence of seven
main serotypes (A, O, C, Asia1, South African Territor-
ies (SAT) 1, SAT2, and SAT3). In addition, numerous
variants and subtypes have been further evolved from
each serotype [1]. Given that cross-reactivity varies, anti-
genic diversity among these serotypes have to be consid-
ered during vaccine development [5].
FMDV virion has a symmetric protein shell (or cap-
sid) enclosing the genomic RNA. Genome RNA con-
tains a positive single-strand chain approximately 8.3
kb long and encodes a single long open reading frame
(ORF) of about 7 kb with two alternative initiation sites.
The ORF is flanked by a long 5ʹ-untranslated region
(5ʹ-UTR) and a short 3ʹ-UTR, and ends with a genetic-
ally encoded poly-(A) tail [6]. A genome-linked viral
nonstructural protein (NSP), 3B (also known as VPg)
containing 23–24 amino acid (aa) residues, is covalently
bound to its 5ʹ end, although this protein is rapidly re-
leased into an infected cell and is deemed to play no
part in translation initiation [7]. The viral ORF can be
translated into a polyprotein of about 250 kDa, which is
subsequently cleaved by two virus-encoded proteinases
(leader (Lpro) and 3Cpro) to yield structural and NSPs
[8, 9] (Fig. 1).
The FMDV genome was completely sequenced, and all
cleavage sites involved in the processing of polypeptides
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were also identified in the past two decades. Generally,
the ORF region in FMDV genome is artificially divided
into four functional areas due to the different functions
of mature polypeptides [10], which are shown as follows
(Fig. 1): L region, which is located at 5ʹ end to the capsid
component and codes for Lpro. P1 region, encoding a
precursor for capsid polypeptide, which can generate
four mature capsid proteins (VP4, VP2, VP3, and VP1)
upon cleavage by viral protease. P2 region encodes three
viral proteins (2A, 2B, and 2C) in the middle region of
the genome. And P3 region, which encodes four viral
proteins: 3A, 3B, 3Cpro and 3Dpol, in which, 3C is a viral
protease and 3D an RNA-dependent RNA polymerase
[11]. Actually, primary polyprotein is not strictly proc-
essed into four products as the functional regions by ini-
tial protease, but Lpro, P1-2A, 2BC and P3 by Lpro, 2A
and 3Cpro. The precursors P1-2A, 2BC and P3 are fur-
ther processed into mature viral proteins and some
cleavage intermediates with relative stability, such as
VP0 or 1AB, 3ABC, 3BCD, 3AB, and 3CD by 3Cpro
(Fig. 1). Usually, the intermediates may perform func-
tions other than those of their individual constituents.
Fig. 1 Schematic diagram of FMDV genome, processing of viral polypeptide and conformations of the structural proteins. FMDV genome RNA
contains a single open reading frame (ORF) of about 7 kb with two alternative initiation sites. The ORF is flanked by a long 5ʹ-untranslated region
(5ʹ-UTR) and a short 3ʹ-UTR. 3B (VPg) is covalently bound to its 5ʹ end. The ORF region is generally divided into four functional areas (L, P1, P2
and P3) due to the different functions of mature polypeptides. ORF-encoded polyprotein is processed into four products, Lpro, P1-2A, 2BC and P3
by Lpro, 2A and 3Cpro. The precursors P1-2A, 2BC and P3 are further processed into mature viral proteins and some cleavage intermediates with
relative stability, such as VP0 or 1AB, 3ABC, 3BCD, 3AB, and 3CD by 3Cpro. Structural proteins form the biological protomer and viral capsid
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The virus capsid consists of 60 copies of each of the
four structural polypeptides (VP1 to VP4), which are
self-assembled into an icosahedral structure with a
diameter of 30 nm [12, 13] (Fig. 1). Studies on structural
information and protein interaction have shown that the
structural protein or the precursor products VP0 (VP2/4
or 1AB), VP1 (1D), and VP3 (1C), which are encoded by
P1 region, form immature protomers through weak
chemical bond interaction. Then, pentamers are assem-
bled by five protomers [14]. After self-assembly of penta-
mers to generate an empty capsid, the viral genomic
RNA covalently linked to VPg at the 5ʹ end enters the
capsid to produce pro-virion. Then the pro-virion is
eventually processed into a mature virion following the
RNA-triggered auto-cleavage of VP0 [15]. Finally, the
virion particles with complete assembly are released
from the infected host cells (Fig. 2).
Viral non-coding elements (NCEs) and NSPs play es-
sential roles in FMDV-induced viral evasion. This review
focus on the molecular biology of FMDV, along with the
functional roles of FMDV NSPs and NCEs in viral
replication and virulence, to elucidate how FMDV
evades the host immune response and evolves into such
an aggressive pathogen.
Functions of FMDV NCEs
5ʹ-UTR
The 5ʹ-UTR is a central element that initiates replication
and translation of the picornavirus genome. Similar to
other picornaviruses, the FMDV RNA genome does not
contain the 5ʹ-terminal cap structure (m7GpppN…),
which can be recognized by the translation initiation
machinery in all eukaryotic cells [16]. Instead, a short
viral protein, 3B or VPg, is covalently linked to the 5ʹ
end of the viral RNA [8]. FMDV is unique among the pi-
cornaviruses as it encodes three non-identical copies of
3B in tandem (see Section 3.3).
FMDV RNA, which consists of a long 5ʹ-UTR contain-
ing over 1300 nucleotides (nt), exhibits extensive sec-
ondary structure and is commonly divided into five
regions (Fig. 3). The first element of the 5ʹ end is the S-
fragment with approximately 350 nt long. Its sequence is
Fig. 2 Life cycle of FMDV in host cells. NSPs, non-structural proteins. HS, heparan sulfate. Green line, viral positive-strand (+) RNA. Orange line, viral
negative-strand (-) RNA
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highly base-paired and capable of folding into a long
stem-loop. Although this highly structured segment has
not been extensively studied, this portion is presumed to
prevent host exonuclease function to maintain viral gen-
ome stability and replication [8].
Following S-fragment is a poly(C) tract exhibiting a vari-
able length of 150–200 nt in typical field strains. Investiga-
tions on genetically engineered viral genome revealed that
a certain threshold length of poly(C) is required to rescue
live virus, although no evidence has shown that poly(C)
tract length is directly associated with virulence [17]. On
the 3ʹ end of the poly(C) tract is a variable region folded
as multiple pseudoknots (PKs) (2–4) [18, 19]. The func-
tion of this element remains unknown, but it is possibly
associated with the poly(C) tract [16].
Downstream of the PK region lies a 3B-uridylylation
site (bus), also known as cis-acting replication element
(cre), which is a highly conserved stem-loop of 55 nt and
Fig. 3 FMDV 5ʹ-UTR provides structural basis for initiation of viral protein translation. a Schematic representation of the structural elements within
the FMDV 5ʹ-UTR. The 5ʹ-UTR is highly structured and comprises S-fragment, poly(C) tract, 3B-uridylylation site (bus) or cis-acting replication element
(cre), pseudoknots (PKs), and internal ribosome entry site (IRES). The organization of the IRES element in different domains (I, II, III, IV, and V) is indicated.
Domain I (the first 20 nt of the IRES) belongs to the right arm of bus. The conserved AAACA, GNRA, RAAA motifs, C-rich loop and polypyrimidine tracts
are also indicated. The two different initiator codons AUG1 and AUG2 are separated by 84 nt. Note that the stems indicated are not perfectly base-
paired. b Intact eIF4G is required in cap-dependent protein synthesis of cellular mRNA. The initiation factors are required for the assembly of
48S initiation complex on a capped cellular mRNA. c Involvement of translation initiation factors in IRES-dependent protein synthesis. The
FMDV IRES elements are indicated. The factors shown are eIF4E (4E), eIF4G (4G), eIF4A (4A), and eIF2 (2) (as part of the ternary complex eIF2/
GTP/met-tRNA), along with small ribosomal subunit (40S)
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is essential for viral genome RNA replication [20]. This
element is commonly consisted in different picornavirus
RNAs, and all picornavirus bus elements contain a con-
served “AAACA” motif in the loop region. This motif
acts as the template for uridylylation of VPg (3B) to pro-
duce VPgpU and/or VPgpUpU, collectively termed as
VPgpU(pU), by the viral RNA polymerase 3D [21, 22].
VPgpU(pU) serves as a primer that initiates viral RNA
synthesis. Interestingly, most known viral bus structures
are embedded in protein-coding regions of the viral gen-
ome, except for that of FMDV, which has a bus structure
that lies in the 5ʹ-UTR region [8]. Alteration in the con-
sensus “AAACA” motif disrupts viral genome replication
but does not significantly affect RNA translation in
FMDV [20]. Moreover, FMDV is temperature sensitive
(ts), and viral replication is greatly suppressed at non-
permissive temperature. Mutant analysis reveals that the
ts element is located within the bus sequence [23], indi-
cating that “cre” also functions in trans.
The last portion of the 5ʹ-UTR is the internal ribo-
some entry site (IRES) element, a type II IRES element
[24]. Consisting of approximately 450 nt, the IRES elem-
ent is required for cap-independent internal translation
initiation of viral RNA [20, 25]. FMDV IRES has five do-
mains and forms multiple stem-loops (Fig. 3a). There
are evidences to support that these domains are involved
in translational control. Some highly conserved se-
quences exist in these domains, like Domain II contain-
ing a polypyrimidine tract (UCUUU) that provides a
polypyrimidine tract-binding protein (PTB) binding site
[26]. Domain III includes two conserved essential motifs,
GNRA and RAAA (N is any nucleotide and R stands for
purine) at the apical region, and a conserved C-rich loop
at the middle region [27, 28]. Modification of the 5ʹ-G
or 3ʹ-A residue of GNRA both greatly diminish the ac-
tivity of FMDV IRES [27, 29] and mutation of RAAA
shows abolished activity of FMDV IRES [28, 30], sug-
gesting that they are important for IRES activity. This
domain also plays a key role in RNA–RNA interactions
and RNA–protein interactions in FMDV [31]. Domain
IV is arranged into two stem-loop structures containing
A-rich internal bulges in FMDV, and it is responsible for
the interaction with eIF4G, an essential translation ini-
tiation factor for IRES-mediated translation initiation
in FMDV [32, 33]. Domain V consists of a conserved
hairpin-loop region and a polypyrimidine-rich tract se-
quence at 20 nt upstream of the initiation codon AUG
[34], which is crucial to identify and initiate viral pro-
tein synthesis. Some mutations in this region are highly
detrimental to IRES activity in FMDV [25] (Fig. 3a).
Translation of FMDV RNA
The featured IRES element is an essential structural re-
gion for initiation of protein synthesis in picornavirus
genome RNA [25, 35, 36]. The IRES is a cis-acting RNA
sequence that adopts diverse three-dimensional struc-
tures to recruit the translation machinery using a mech-
anism that is independent on the 5′end [37]. Nearly all
canonical cellular translation initiation factors are re-
quired for IRES-dependent initiation of translation in
FMDV except eIF4E, a cap-binding protein [16, 38],
consistent with the fact that FMDV genome RNA lacks
the cap structure on the 5ʹ end (Fig. 3b and c). For most
cellular mRNAs, the 5′cap structure is recognized by
eIF4F, a trimeric complex composed of eIF4A (an RNA
helicase), eIF4E (a specific cap structure-binding pro-
tein), and eIF4G (a scaffold protein). The scaffold pro-
tein eIF4G interacts with eIF4A, PABP and the
multimeric factor eIF3. The complex bound to the 40S
ribosomal subunit is recruited to the mRNA along with
other factors, resulting in eukaryotic protein synthesis
[38] (Fig. 3b). Cleavage of eIF4G by viral Lpro removes
its N-terminal portion, the binding sites for eIF4E,
impairing cap-dependent protein synthesis in host
cells. By contrast, the C-terminal portion of eIF4G re-
tains the binding sites for eIF4A and eIF3, which is suf-
ficient for FMDV IRES activity.
However, viral IRES are characterized by the presence
of ignored AUGs upstream of the functional start codon,
heavy RNA structure and high GC content [39, 40]. Des-
pite being unable to direct cap-dependent translation,
the C-terminal portion of eIF4G is fully efficient in
FMDV IRES-driven translation [16, 41]. Reconstitution
assays have demonstrated that assembly of initiation
complexes into IRES element requires either the intact
type or C-terminal fragment of eIF4G, in addition to
eIF4A, and eIF3 [42, 43]. Moreover, eIF4G, either the in-
tact type or the C-terminal cleavage product, directly in-
teracts with IRES in domains III and IV [44]. eIF4A and
eIF3, which bind to eIF4G, also indirectly interact with
IRES to participate in IRES-directed translation initi-
ation. eIF4B, another factor that directly interacts with
IRES at domain IV, also affects the activity of IRES, al-
though the effect is rather modest [45].
In addition to the eIFs described above, many other
cellular proteins are also involved in the modulation
(stimulate or repress) of IRES activity. They are all
termed IRES-transacting factors (ITAFs), including PTB,
PCBP2, the SR splicing factor (SRp20), the far upstream
element binding protein 2 (FBP2), the lupus antigen (La),
unr (upstream of N-ras), nucleolin, or Gemin5, etc [46].
The polypyrimidine PTB was the first protein identi-
fied as an ITAF [25, 47, 48]. PTB contains four RNA rec-
ognition motifs (RRM) to recognize U/C-rich sequences.
PTB directly binds to polypyrimidine tracts on IRES
element to stimulate IRES activity in FMDV [47]. The
poly(C) binding proteins, PCBP1 and PCBP2, also
recognize and interact with FMDV IRES domain II, but
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the depletion test showed that such an interaction site is
not indispensable for FMDV IRES activity [41, 49].
Moreover, secondary protein–protein or RNA-protein
bridges could facilitate IRES activity. As examples, SRp20
enhances IRES-mediated translation via its interaction
with PCBP2 [50]. ITAF45 (also known as Ebp1), together
with PTB, sharing the same binding region in IRES, co-
operatively stimulate FMDV IRES activity [51]. Later stud-
ies found some ITAFs of IRES downregulators. For
example, Gemin5, a cytoplasmic protein that binds dir-
ectly to the FMDV IRES and down-regulates translation
[52]. Besides, FBP2 negatively regulates EV71 IRES activity
[53], and the double stranded RNA-binding protein
DRBP76:NF45, is a nuclear heterodimeric protein that in-
teracts with HRV IRES and represses its activity [54].
As a consequence of in depth RNA–protein inter-
action studies performed with picornavirus IRES, the list
of ITAFs is still growing incessantly [55]. The Glycil
tRNA synthetase (GARS) emerges as a class of novel
ITAFs stimulating picornavirus IRES activity [56]. Pre-
dictably, more ITAFs will be identified in the near fu-
ture, which will help to provide more details about
interactions of IRES-proteins within host cells.
3ʹ-UTR
FMDV RNA 3ʹ-UTR consists of two components, a
structural sequence of 90 nt folding into two separate
stem-loops and a poly(A) tail with variable length
[16, 57] (Fig. 1). These elements are both involved in
viral replication and virulence [24]. Molecular biology
studies have demonstrated that the structured 3ʹ-
UTR directly binds to S-fragment and IRES elements
at two distinct positions in the 5ʹ-UTR through spe-
cific long-range RNA–RNA contact pattern [57].
IRES-3ʹ-UTR interaction requires both stem–loop
structures of 3ʹ-UTR, which stimulates IRES activity
and is independent of the poly(A) tail. Whereas the
S-fragment interacts with each of the stem–loops and
is dependent on the poly(A) tail [57]. These findings
indicated that the 3ʹ-UTR enhances IRES activity and
determines the virulence of FMDV. Moreover, genetic
evidence reveals that recombinant FMDV with a deleted
structural sequence in 3ʹ-UTR cannot be recovered [58],
demonstrating that the structured region in the 3ʹ-UTR is
essential for FMDV infectivity and replication.
In addition to direct RNA-RNA interaction, 5′–3′ end
bridges could also involve protein-protein and protein–
RNA interaction. Studies found that cellular proteins
PCBPs and p47 can both interact with the S region and
3ʹ-UTR by directly binding to them [57]. As mentioned
in the above section, SRp20 directly interacts with
PCBP2, and Ebp1 cooperates with PTB to stimulate viral
genome translation, raising the possibility that secondary
protein–protein bridges take important roles in RNA–
RNA interaction between 5ʹ and 3ʹ ends to modulate the
viral genome translation in FMDV.
Functions of FMDV NSPs
Lpro
The viral protein Lpro is a region in the polyprotein pre-
ceding the capsid precursor protein [59]. Lpro, the first
protein in FMDV to be translated, is initiated at two dif-
ferent start codon AUGs separated by 84 nt. Lpro has
two alternative forms, namely, Labpro and Lbpro. Both
forms have been detected in vitro and in vivo [60, 61].
Lbpro protein (synthesized from the second AUG) is the
major protein type in vivo. Viable viruses can be recov-
ered from synthetic genomes containing mutations in
the first AUG but not in the second [62, 63]. The se-
quence between the two AUGs are possibly involved in
start codon recognition through interactions with a
regulatory factor [62, 64]. FMDV Lpro is a well-
characterized papain-like proteinase [65–67] that re-
leases itself from the polyprotein via cleavage between
its own C-terminus and the N-terminus of VP4 at the
sequence ArgLysLeuLys ↓ GlyAlaGlySer during viral
maturation [66, 68].
Lpro is an important determinant of virulence. Previous
studies showed that the Lpro-deleted virus shows only a
slightly slower replication rate than the wild-type (WT)
virus [63] but exerts a dramatically lower ability to cause
lesions during intradermal injection [69] and fails to
cause clinical signs of FMD when exposed to aerosol con-
taining high doses of leaderless virus in cattle and swine
[70, 71]. Thus, Lpro is not required for viral replication but
is indispensable for the pathogenesis of FMDV.
Lpro also represses host cell translation by cleaving the
translation initiation factor eIF4G [8, 66]. Strong evi-
dence confirmed that Lpro recognizes and cleaves the
crucial host translation initiation factor eIF4G at the site
between Gly479 and Arg480 [66, 72, 73]. eIF4G is a key
scaffold protein for the attachment of other translation
initiation factors to exert their functions. Cleavage of
eIF4G directly shuts off host cap-dependent mRNA
translation [73, 74]. By contrast, FMDV RNA, which
initiates translation in a cap-independent manner via
its IRES element, does not require intact eIF4G. Re-
moval of the N-terminus of eIF4G by Lpro does not im-
pair viral RNA translation initiation. Thus, FMDV
freely uses the host protein synthesis machinery to
synthesize viral protein (Fig. 3) [8].
Lpro blocks interferon (IFN) activity directly and indir-
ectly by inhibiting the central upstream regulatory factor
[75–77]. IFN induction is one of the most important
host innate immune response to viral infection [78]. Se-
creted IFN proteins bind to neighbor cells by paracrine
manner to induce the expression of a number of IFN-
stimulated genes to mediate various biological responses
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[79], including inhibition of viral replication. Notably, in-
fection with leaderless virus, which lacks the Lpro coding
region, induces higher levels of type I IFN (IFN-α and
IFN-β) mRNA level than WT virus, and type I IFN
downstream signaling can only be detected in cultures
with the leaderless virus infection [75, 76, 80]. Therefore,
type I IFNs, including their mRNAs and proteins, are
limited by viral Lpro. Lpro also inhibits dsRNA-induced
IFN-λ1 expression, which is a type III IFN demonstrat-
ing significant antiviral activity against FMDV [77].
No evidence demonstrated the direct cleavage of IFNs
by Lpro. Translational repression of IFNs is probably re-
sulted from the blocking of FMDV Lpro-induced cap-
dependent mRNA translation by Lpro-mediated cleavage
of eIF4G [8, 81]. Further studies have attempted to in-
vestigate the molecular mechanism of Lpro virulence.
Promoter activity and protein studies have shown that
FMDV Lpro down-regulates interferon regulatory factor
3/7 (IRF-3/7) expression both at the transcription and
translation levels [82, 83]. IRF-3/7 are important regula-
tors in RIG-I/MDA5-induced innate immune signaling,
a crucial pathway response to infections caused by picor-
naviruses [84]. Their inhibition suppresses the expres-
sion of type I IFNs and downstream cytokines, including
IFN-α/β and CCL5, also known as RANTES [82, 83].
A recent study found that FMDV Lbpro is a novel viral
deubiquitylation (DUB) enzyme [85]. Ubiquitination and
deubiquitination, which are a class of important regula-
tion patterns, are critically involved in many signaling
cascades, including virus-induced type I IFN signaling
[86]. Viruses are connected to ubiquitin and ubiquitin-
like modifiers in a variety of ways [87, 88]. Sequence
analyses revealed that catalytic residues (Cys51 and
His148) are highly conserved in Lbpro, the shorter form
of Lpro, in all seven serotypes. The topology of FMDV
Lbpro is remarkably similar to that of some known
DUBs, such as ubiquitin-specific protease 14, a cellular
DUB [89], as well as severe acute respiratory syndrome
coronavirus (SARS-CoV) papain-like protease (PLpro), a
coronaviral DUB [90]. In addition, Biochemical and
molecular evidence also revealed that FMDV Lbpro can
remove ubiquitin (Ub) moieties from cellular sub-
strates, function on both lysine-48- and lysine-63-
linked polyubiquitin chains, a feature shared by other
known viral DUBs, such as human cytomegalovirus
UL48, herpes simplex virus type 1 UL36, and SARS-
CoV PLpro [91, 92], indicating that FMDV Lbpro ex-
hibits deubiquitinating activity. A new mechanism of
Lpro blocking IFN antiviral response is revealed by the
evidence that Lpro antagonizes type I IFN induction by
deubiquitinating the critical signaling components RIG-
I, TBK1, TRAF3, and TRAF6 [85].
To sum up, FMDV Lpro generally functions as a multi-
functional protein that blocks IFN-mediated antiviral
response via multiple distinct mechanisms (Fig. 4): (1)
Lpro shuts off host cell translation through cleavage of
the translation initiation factor eIF4G, suppressing IFN
protein expression [93]; (2) Lpro represses IFN activity by
inhibiting activation of central upstream regulatory fac-
tors, including NFkB and IRF-3/7 [82]; and (3) Lpro acts
as a DUB and cleaves ubiquitin chains from RIG-I,
TBK1, TRAF3, and TRAF6, thereby inhibiting type I
IFN signaling [85].
2A Protein
The P2 portion in the picornavirus genome encodes
three mature viral proteins, namely 2A, 2B, and 2C
(Fig. 1). FMDV 2B and 2C are partially homologous to
other picornavirus, whereas FMDV 2A is only an 18 aa
peptide [94] and is much shorter than the other picorna-
virus members but highly conserved with cardiovirus at
the 2A/2B junction. The FMDV 2A protein lacks any
protease motifs and only contains the characteristic C-
terminal motif “-Glu(x)AsnProGly(2A)/Pro(2B)-” [95]. In
addition, the conserved cleavage site is located between
2A and 2B Gly(2A)/Pro(2B) [94, 96]. Mutation research
confirmed that Gly (2A) is the most important amino
acid for cleavage activity at the 2A/2B junction [97, 98],
whereas recombinant FMDV sequence containing muta-
tion in the 2A peptide can produce uncleaved proteins.
Moreover, cleavage between 2A and 2B only occurs as a
co-translational event. Thus, the 2A cleavage event oc-
curs only during polypeptide synthesis [95], such that
the 2A peptide remains connected to the P1 structural
protein precursor (P1-2A) following primary cleavage of
the polyprotein [99]. 2A is cleaved from the P1-2A pre-
cursor either by 3Cpro or 3CDpro [100].
The FMDV 2A peptide, along with the first aa of the
2B protein, can mediate cleavage in artificial polyprotein
systems [94, 95]. However, this FMDV 2A-mediated arti-
ficial polyprotein cleavage does not work in the prokary-
otic system [94]. In addition, the synthesized upstream
proteins of the 2A sequence are always present in
greater molar excess than the downstream proteins of
the 2A sequence [95]. Thus, the 2A-2B cleavage event is
not a proteolytic event but a modification of the transla-
tional machinery by the 2A peptide, allowing the release
of the protein-2A from the ribosome while permitting
the synthesis of the downstream proteins to proceed [95,
96].
2B Protein
Picornaviruses 2B are viroporins, a class of low-
molecular-weight hydrophobic transmembrane proteins
encoded by a wide range of animal viruses. The trans-
membrane hydrophobic domains interact with the
phospholipid bilayer to induce dispersion, increasing
membrane permeability and promoting the release of
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viral particles. Thus, viroporins are crucial for viral
pathogenicity [101, 102].
Knowledge on FMDV 2B is limited. FMDV 2B en-
codes a 154 aa peptide, which is slightly longer than
other viroporins and contains two predicted putative
transmembrane domains located in 83–104 aa and 119–
137 aa, respectively [103]. Topology studies have shown
that FMDV 2B is located in the endoplasmic reticulum
(ER) and exhibits a transmembrane topology similar to
that of class IIB viroporins, which consist of two trans-
membrane domains and their N- and C-termini both ex-
tend to the cytoplasmic matrix [103]. Similar to other
known viroporins, FMDV 2B induces damage to the in-
tegrity of the host cell’s membrane and causes Ca2+ ab-
normalities, activating autophagy [103]. However, this
phenomenon has not yet been fully confirmed in FMDV.
Some reports have indicated that 2B functions syner-
gistically with other viral proteins, such as 2C, in FMDV
[104]. Previous findings have also confirmed that picorna-
viral infections block protein secretion in host cells.
Rather than other picornaviruses, ER-to-Golgi apparatus
protein transport in FMDV is blocked by the 2BC precur-
sor protein but not by 2B or 2C. Microscopy and immu-
noprecipitation indicated that the 2BC protein blocks
cellular protein transport between the ER and Golgi ap-
paratus during FMDV infection [105], and a study showed
that protein transport was abolished only in the case of
both 2B and 2C co-expression [104]. This phenomenon is
possibly caused by the synergistic effect of 2B and 2C.
Viroporins participate in multiple stages of the viral
life cycle, such as cell entry and genome replication. Vi-
ruses with viroporin deletion cannot properly assemble
and release from cells [102, 106]. Thus, viroporins are
attractive targets for antiviral therapy based on recent
findings on their structure and biological functions.
Several viroporin inhibitors have been developed to
Fig. 4 Known functions of FMDV nonstructural proteins on cellular regulation. Purple circles: FMDV nonstructural proteins. Red arrow: activation
of downstream gene expression. Orange line with vertical stub: inhibition of downstream proteins. kB, a canonical kB element response to
Nuclear factor kB (NF-kB). ISRE, IFN-sensitive response element. Caspases, represent a class of genes inducing apoptosis and inflammation
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effectively suppress viral replication through inhibition
of membrane permeabilizing activities. These inhibitors
include amantadine, which is used against hepatitis C
virus (HCV) p7 and influenza A virus M2 protein; 4,4ʹ-
diisothiocyano-2,2ʹ-stilbenedisulphonic acid [107], which
is against enterovirus 71 P2B protein; 5-(N,N-hexam-
ethylene) amiloride (HMA), against HIV-1 Vpu, HCV
p7, and SARS-CoV E protein; and N-(5-(1-methyl-1H-
pyrazol-4-yl)-napthalene-2-carbonyl)-guanidine
(BIT225), which can also inhibit HIV-1 Vpu and HCV p7
[102, 108]. Although no reports demonstrated the effect
of these drugs on FMDV replication, these findings pro-
vide potential strategies for developing antiviral drugs
against FMDV viroporin 2B.
2C Protein
Protein 2C is one of the highly conserved molecules
among the viral proteins encoded by FMDV, and 2C-like
(2CL) proteins generally exist in many other RNA vi-
ruses across animals and plants [109]. The FMDV pro-
tein 2C is a 318 aa polypeptide that contains a predicted
amphipathic helix in its N-terminus (residues 17–34)
[110, 111]. It is responsible for many biological functions
linked to membrane targeting. Although the reports
about FMDV 2C are limited now, a number of studies
have uncovered the function of other picornaviruses 2C.
FMDV 2C is the largest membrane-binding component
of the virus RNA replication complex and is speculated
to perform a function similar to the 2C in other picorna-
viruses [104, 112]. 2C plays a key role in both membrane
rearrangement and formation of the viral replication
complex. In addition, 2C is implicated in virus-induced
cytopathic effects [113–116]. Immunofluorescence stud-
ies demonstrated that protein 2C aggregates at the cellu-
lar periphery in FMDV-infected cells [117] and is
inclined to bind to ER [118]. These findings are consist-
ent with those of subcellular fractionation studies, which
revealed that 2C co-localizes with the ER membrane,
Golgi apparatus, and lysosomes in poliovirus [119–122].
2C also co-localizes with the membrane-bound replica-
tion complex, suggesting that 2C acts as an important
factor in viral replication. This function is also con-
firmed by the inhibition experiments. Guanidine hydro-
chloride, an antiviral compound and a molecular
antagonist against protein 2C can inhibit viral RNA syn-
thesis in picornavirus-infected cells, and virus strains
containing guanidine-resistant (gr) 2C mutation cannot
be inhibited by guanidine hydrochloride, providing dir-
ect evidence that FMDV 2C protein plays a key role in
virus replication [123, 124]. This phenomenon is also
observed in poliovirus [111, 125, 126]. Notably, FMDV
2C is only present when the replication complex forms
during virus proliferation but absent from clarified virus
stocks used for vaccine preparation. Thus, 2C protein
can be used to differentiate potential carrier convales-
cent animals from vaccinated livestock [127–130].
Many other functions of 2C in other picornavirus
members have been reported, including viral RNA bind-
ing activity [131, 132], NTP binding activity [109],
ATPase and GTPase activities [133, 134], binding to
Reticulon 3, as well as viral replication [135]. Given that
2C proteins are highly conserved among picornavirus
members, FMDV 2C is speculated to demonstrate most
of these activities. Indeed, some functions of FMDV 2C
have been confirmed [136].
A recent report discovered that FMDV 2C is involved
in apoptosis induction and type 1 IFN response. Yeast
two-hybrid system and immunoprecipitation approaches
revealed that FMDV 2C interacts with N-myc and
STAT interacting (Nmi) protein [137], a factor involved
in multiple cell signaling by interacting with many pro-
teins, including IFN signaling and apoptosis signaling
[138–140], as well as its heterodimeric complex partner,
IFN-induced 35-kDa protein (IFP35) [137], a protein
with potential roles in apoptosis, cytokine response,
and antiviral activity [141–143]. Moreover, immunopre-
cipitation and immunofluorescence studies indicated
that 2C can recruit Nmi and IFP35 into the intracellu-
lar membrane structure by changing their subcellular
distribution, forming the 2C-Nmi-IFP35 complex. Thus,
2C likely induces apoptosis through the host protein Nmi,
as well as induces a type I IFN response through the host
protein IFP35 [118, 137, 144]. Nevertheless, some studies
indicated that apoptosis does not occur in FMDV-infected
cells [145, 146]. Further investigation is needed to clarify
the underlying mechanism of FMDV and apoptosis.
Some other research reported that FMDV 2C is in-
volved in FMDV-induced autophagy. FMDV triggers
cellular autophagy and enhances viral replication [147].
Gladue et al. further investigated the interaction be-
tween FMDV 2C and cellular Beclin1 using a yeast
two-hybrid model, immunoprecipitation and confocal
microscopy. They found that FMDV 2C binds to
Beclin1, a factor that plays dual roles in the autophagy
pathway. Beclin1 is involved in initiation of autophago-
some formation and fusion of autophagosome to lyso-
some [148, 149]. So 2C-induced Beclin1 inactivation
blocks the fusion of FMDV-containing autophagosomes
to lysosomes and prevents virus degradation [150]. 2C-
Beclin1 interaction plays a significant role in virus rep-
lication [150].
Viral 2C protein is speculated to act as an important
regulator integrating multiple cell signaling during
FMDV infection, including apoptosis, immune response,
and autophagy. This protein reduces the cellular killing
effect against viruses and promotes virus survival and
proliferation, thereby facilitating viral proliferation and
release of virus particles (Fig. 4).
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3A Protein
FMDV 3A protein is a 153 aa peptide, which is larger
than other picornaviral 3A protein, like the 87 aa-long
poliovirus 3A [8]. FMDV 3A is conserved in most
FMDV strains. Half of the 3A coding region in the N-
terminus (positions 1–75) encoding a hydrophilic do-
main and a hydrophobic domain capable of binding to
membranes, is highly conserved in all FMDV strains
[151]. By contrast, many mutations and deletions occur
in the C-terminus of all FMDV strains.
Based on its hydrophobic motifs, FMDV 3A exerts
membrane binding activity [105]. Fluorescent staining
revealed that 3A in infected cells partially co-localizes
with the ER marker calreticulin and with Golgi stacks
protein p58 [152]. In contrast to other picornaviruses,
transient expression of 3AB proteins does not induce
major rearrangements of intracellular membranes as in-
ferred from immunofluorescence and electron micros-
copy studies [152]. FMDV 3A preferentially localizes in
small vesicles when transiently expressed [105]. Rosas et
al. [153] generated BHK21 cell lines stably expressing
3A and its precursor 3AB and found that expression
levels of 3A and its processors exert varying degrees
of cell toxicity but do not induce cell membrane rear-
rangements [153]. In addition, stable expression of 3A
or 3AB protein enhances FMDV replication, including
increase of virus plaque formation and virus titers. But
transiently expressing 3AB protein shows a decreased
level of FMDV infection. These indicated a transacting
role of 3A and 3AB on the FMDV multiplication cycle
[153].
Reports demonstrated that 3A plays a role in virulence
and host range. Some amino acids substitutions or dele-
tions in 3A protein are associated with change in host
range and tropism of FMDV [154, 155] and other picor-
naviruses, including poliovirus and human rhinovirus
[156]. In the N-terminus of 3A, the amino acid substitu-
tion Q44 to R is sufficient to confer FMDV C-S8c1
strain adaptation to guinea pig [155]. Two kinds of nat-
ural deletion mutants were reported in the C- terminus:
10 aa deletion at positions 93–102 and 11 aa deletion at
positions 133–143 [154, 157]. The 133–143 deletion in
3A was observed in both cattle and pig isolates and does
not affect the host range and virulence of FMDV [151].
By contrast, the 93–102 deletion in 3A is associated with
high virulence in swine and is observed in a variant of
FMDV serotype O isolated in Taiwan in 1997 (O/TAW/
97). This deletion severely affected swine but did not
spread to cattle [154, 157, 158], and also reduced virus
replication efficiency in bovine cells but not in swine
cells [159]. Similar deletion mutants containing 19 aa
(O1C-O/E) to 20 aa (C3R-O/E) deletions in 3A protein
were also observed in egg-adapted attenuated strains.
These mutants displayed reduced virulence in cattle
and were used for early vaccine development [154,
158]. Another artificial mutant containing 20 aa dele-
tion at positions 87–106 of 3A demonstrated a signifi-
cantly reduced replication ability and attenuated
virulence in cattle [157]. Although its underlying mech-
anisms remain unclear, FMDV 3A is another viral pro-
tein affecting FMDV virulence, and some positions in
3A are associated with alterations in viral virulence and
host range as indicated by the aforementioned studies.
In addition to 2C protein, 3ABC, the 3A precursor, is
also used to differentiate potential carrier from vacci-
nated animals both in cattle and swine [160]. Actually,
3ABC is the most antigenic protein among all NSPs and
is the best serological indicator of infection with FMDV
[160]. Various ELISAs based on 3ABC antigen or anti-
body have been developed for discrimination between
infected and non-infected animals regardless of their
vaccination status [160–163].
3B Protein
Protein 3B, which is also known as VPg, is covalently
bound to the 5ʹ terminus of the genome and antigenome
and primes picornavirus RNA synthesis [8]. In contrast
to other picornaviruse that encode a single copy of 3B,
the FMDV 3B protein is unique because it exists in three
similar but non-identical copies (3B1, 3B2, and 3B3),
which are 23–24 aa long [164]. No natural FMDV strains
have been reported to contain fewer than three copies of
3B [165], although not all three copies of FMDV 3B are
needed to maintain infectivity [164], suggesting that
there is a strong selective pressure towards maintaining
this redundancy.
Uridylylation of the VPg peptide primer is the first
stage in the replication of the picornavirus genome
(Fig. 2). The picornavirus genome has a 5ʹ terminal fea-
ture of VPgpU(pU) covalently linked, which contributes
to the use of VPg as a peptide primer to synthesize viral
RNA. This peptide attaches to RNA via a conserved
Tyr3 residue through the action of viral RNA polymer-
ase (3Dpol). In this process, the viral 3Dpol catalyzes the
binding of two uridine monophosphate (UMP) mole-
cules to the hydroxyl group of this Tyr3 using as tem-
plate a cis-replicating element (bus/cre) in FMDV
genome [166]. Three isoforms of FMDV 3B (3B1, 3B2,
and 3B3) can all be uridylylated in vitro, although 3B3 is
likely the most efficient substrate for 3Dpol activity [167].
VPg peptide primer uridylylation can be performed in
vitro using purified components, including VPg (3B)
with 3Dpol, 3CD precursor, UTP, and an RNA template
containing a stem-loop structure (bus) [167].
VPgpU(pU) are produced during this reaction and syn-
thesis of positive- and negative-sense RNAs is initiated
[166, 168].
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A reverse genetics study demonstrated that deletion of
the 3B3 coding sequence exerts a deleterious effect on
FMDV RNA replication, resulting in production of a
non-infectious RNA transcript [167, 169]. Laboratory re-
combinant virus lacking 3B1 and 3B2 also reduces viral
RNA synthesis levels and infective particle formation in
vitro, attenuats disease in pigs, but not drastically [170].
These studies indicated that 3B3 is more important than
3B1 and 3B2 to maintain viral RNA replication, but co-
existence of all three 3B copies exerts the best RNA rep-
lication efficiency. Whereas the underlying mechanisms
of their respective roles on viral RNA replication and
how the three copies are integrated during viral replica-
tion still require further investigation.
3Cpro
FMDV 3C proteinase, responsible for most cleavages
of viral polyprotein, was recently identified as a
chymotrypsin-like cysteine protease [8, 171], although
its function and catalytic residues were reported since
1995 [172]. Crystal structure and mutagenic research
in FMDV demonstrated that a featured apolar surface
loop containing a β-ribbon structure that folds over
peptide binding cleft and clearly contributes to sub-
strate recognition is important for catalytic activity. In
addition, Cys142 in the Cys-His-Asp/Glu catalytic
triad at the tip of the β-ribbon significantly affects en-
zyme activity [173, 174]. Except for the autocatalytic
cleavage of Lpro from P1, 2A cleavage between P1-2A
and 2BC, and maturation cleavage of VP0 to VP2 and
VP4, 3Cpro can efficiently process all other 10 cleavage
sites in FMDV polyprotein although the rate of cleav-
age varies at different junctions [175]. FMDV 3Cpro
cleavage sites show great heterogeneity, with cleavage
occurring between multiple dipeptides, including Gln-
Gly, Glu-Gly, Gln-Leu, and Glu-Ser [176]. By contrast,
in other picornaviruses, such as poliovirus, the 3Cpro
cleavage site located exclusively between Gln-Gly and
3CDpro is implicated as the major viral proteinase in
structural protein cleavage [176, 177].
FMDV 3Cpro is also associated with inhibition of host
cell transcription and translation. As mentioned above,
FMDV Lpro is involved in eIF4G cleavage, which shuts
off host cell gene translation. FMDV 3Cpro can also
cleave eIF4A, a portion of the cap-binding complex with
the function of an RNA helicase [178]. Compared with
Lpro, FMDV 3Cpro cleaves eIF4G late in the infection
cycle at an alternative site, although it may not be favor-
able for the translation of viral proteins at this stage [8].
Moreover, 3Cpro is the agent that cleaves histone H3 fol-
lowing FMDV infection. Histone H3 is an important
component of nucleosome and is crucial in maintaining
the conformation of nucleosomes, thereby affecting
cellular transcription [179]. FMDV 3Cpro also removes
20 N-terminal aa residues from histone H3, resulting in
inhibition of host cell transcription [180].
Similar to other picornaviruses, FMDV 3Cpro can enter
nuclei through its precursor 3CD, which contains a nu-
clear localization sequence (NLS) in the N-terminus of
the 3Dpol protein [152]. 3Cpro also cleaves multiple fac-
tors and regulators. Recent studies found that FMDV
3Cpro directly cleaves the 68 kDa Src-associated sub-
strate during mitosis (Sam68), one of the nuclear RNA-
binding proteins that participate in viral replication in
cells. Immunofluorescent and immunoblot assays re-
vealed that 3Cpro removes the NLS-containing C-
terminus of the Sam68 protein (~18 kDa). The truncated
Sam68 (~50 kDa) was subsequently redistributed into
the cytoplasm [181]. Moreover, cytosolic Sam68 directly
interacts with the FMDV IRES and enhances the transla-
tion of the viral RNA [181].
Other reports associated FMDV 3Cpro with innate im-
mune regulation (Fig. 4). Wang et al. provided direct evi-
dence that FMDV 3Cpro proteolytically cleaves the
nuclear transcription factor kappa B (NF-kB) essential
modulator (NEMO), a bridging adaptor protein essential
in activating both the NF-kB and IFN-regulatory factor
signaling pathways [182], to reduce RIG-I/MDA5 signal-
ing. They found that FMDV 3Cpro specifically targets the
NEMO Gln383 residue, which lies between the C-
terminal leucine zipper motif and a zinc finger (ZF) do-
main [182]. The ZF domain plays a crucial role in fully
activating NF-kB and IRFs that orchestrate immune and
inflammatory responses [183, 184].
In addition, the picornavirus 3Cpro cleaves many other
factors and regulators associated with cellular DNA-
dependent RNA polymerases I, II, and III, such as
TATA-box binding protein, octamer-binding protein,
transcription activator p53, cyclic AMP-responsive elem-
ent binding protein, and DNA polymerase III [7]. Al-
though many of them have not yet been confirmed for
FMDV, these data indicated that 3Cpro may widely per-
turb gene transcription and translation in host cells.
3Dpol
FMDV 3D protein, the virus-encoded RNA-dependent
RNA polymerase (RdRP) [185], is the catalytic compo-
nent of RNA replication to synthesize positive- and
negative-sense genome and plays an important role in
the life cycle of RNA viruses (Fig. 2). 3Dpol sequences
are highly conserved among the different sero- and sub-
types of FMDV [186]. Picornaviruses use a precursor
3CD as a functional intermediate in viral replication, al-
though 3CD contains an active 3C protease component.
3Dpol remains inactive until protein processing is
complete [187].
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Crystal structure analysis revealed that FMDV 3Dpol
shares similar structure and catalytic mechanism to all
other RNA virus-encoded RdRPs of several other fam-
ilies [187]. The overall structure of 3Dpol imaginatively
resembles a cupped “right hand” consisting of “palm,”
“fingers,” and “thumb” subdomains, which determine the
correct geometrical arrangement of substrate molecules
and metal ions at the active catalytic site [188]. The cata-
lytic site of all RdRPs is contained in the palm domain.
This domain is the most highly conserved feature of all
known polynucleotide polymerases and is composed of
five motifs, a three-stranded antiparallel core β sheet,
and flanked by two α helices. This domain is involved in
structural integrity, nucleotide recognition and binding,
phosphoryl transfer, and priming nucleotide binding. By
contrast, the thumb domain consists of the C-terminal
region of the polypeptide chain and exhibits the most di-
verse feature among the known viral RdRPs [187].
Picornavirus replication is initiated in a primer-
dependent manner. The protein primer VPg provides
the hydroxyl nucleophile and forms a complex with
3Dpol or 3CD, termed VPg uridylylation complex, to ini-
tiate RNA replication in picornavirus [189, 190]. Bio-
chemical and structural studies revealed that three
distinct VPg binding sites on 3Dpol are present among
different members of this family [191]. In FMDV, VPg
binds to the residues in the active site cleft of the poly-
merase in the uridylylation reaction [190]. Whereas, in
coxsackievirus B3 (CVB3), VPg is bound at the base of
the thumb sub-domain [192], and in EV71, VPg is found
anchored at the bottom of the palm domain of the poly-
merase [193]. The conformation of RdRPs changes in
subtle ways to accomplish three steps cycle of replication
elongation process, including nucleotide selection,
phosphodiester bond formation and translocation to the
next nucleotide for the subsequent round of nucleotide
addition (reviewed in [191]).
The structure and biochemical activity of RdRP offer
the opportunity to develop very selective anti-drugs
against this viral enzyme in FMDV. Reports have indi-
cated that some base and nucleotide analogues, par-
ticularly 5-fluorouracil and ribavirin. 5-Fluorouracil, a
pyrimidine analogue, is mutagenic for a number of
RNA viruses, including FMDV [194]. Ribavirin is also
mutagenic for viral RNA polymerases [195] and is use-
ful to eliminate FMDV from persistently infected cells
via enhanced mutagenesis [196].
Conclusions and perspective
FMDV remains a severe pathogen that hampers modern
agriculture worldwide, despite the extensive work has
been conducted in the past several decades to control it.
Traditional vaccine development is limited by the
potential risk of virus transmission. Synthetic capsid vac-
cine, an important novel vaccine against virus infection
is limited because of the high potential for genetic and
antigenic variation [1, 5]. Specific strategies against
FMDV, including antiviral drugs and novel vaccines, are
still required in response to repeated epidemic events.
The NSPs and NCEs of FMDV play a critical role in
viral proliferation and virus–host interaction. Studies on
the involvement of these proteins and elements provided
important insights into the molecular mechanism of
virus-induced diseases. Nearly all NSPs and NCEs of
FMDV are under investigation for their involvement in
either virus detection or potential anti-viral strategy de-
velopment [197–205], although progress is slow. FMDV
is unique among the picornavirus family because of its
long 5ʹ-UTR, three copies of 3B protein and short 2A
protein lacking any protease motifs. Together with our
most recent finding about the molecular mechanisms of
FMDV entry into host cells [206], these properties pos-
sibly contribute to the virulence and pathogenesis of
FMDV. In-depth work is still required to further under-
stand the role of these proteins and elements in FMD
pathogenesis and virus–host interactions. More exten-
sive research will be helpful to uncover effective antiviral
targets.
Acknowledgments
This work was supported by grants from the National Science and Technology
Support Program (2013BAD12B00), International Science & Technology
Cooperation Program of China (2014DFA31890), Fundamental Research Funds
for the Chinese Academy of Agricultural Sciences (2015ZL062), and China
Postdoctoral Science Foundation (2016M591314). We are grateful to Shichong
Han (China Agricultural University) for his help with image processing. We also
would like to thank Liping Yang (University of Maryland) for critical reading of
this manuscript. We apologize to the people whose work cannot be cited due
to space limitation.
Authors’ contributions
YG and SQ S provided the concept and study information. YG and SQ S also
drafted the manuscript. HC G provided the final approval of the version for
submission. All of the authors approved the final version of the manuscript.
Competing interests
The authors declare that they have no competing interest.
Received: 19 February 2016 Accepted: 13 June 2016
References
1. Knowles NJ, Samuel AR. Molecular epidemiology of foot-and-mouth disease
virus. Virus Res. 2003;91:65–80.
2. Haydon DT, Samuel AR, Knowles NJ. The generation and persistence of
genetic variation in foot-and-mouth disease virus. Prev Vet Med. 2001;51:
111–24.
3. Domingo E, Ruiz-Jarabo CM, Sierra S, Arias A, Pariente N, Baranowski E,
Escarmis C. Emergence and selection of RNA virus variants: memory and
extinction. Virus Res. 2002;82:39–44.
4. Domingo E, Pariente N, Airaksinen A, Gonzalez-Lopez C, Sierra S, Herrera M,
Grande-Perez A, Lowenstein PR, Manrubia SC, Lazaro E, Escarmis C. Foot-
and-mouth disease virus evolution: exploring pathways towards virus
extinction. Curr Top Microbiol Immunol. 2005;288:149–73.
5. Klein J. Understanding the molecular epidemiology of foot-and-mouth-
disease virus. Infect Genet Evol. 2009;9:153–61.
Gao et al. Virology Journal  (2016) 13:107 Page 12 of 17
6. Grubman MJ. The 5' end of foot-and-mouth disease virion RNA contains a
protein covalently linked to the nucleotide pUp. Arch Virol. 1980;63:311–5.
7. Lin JY, Chen TC, Weng KF, Chang SC, Chen LL, Shih SR. Viral and host
proteins involved in picornavirus life cycle. J Biomed Sci. 2009;16:103.
8. Mason PW, Grubman MJ, Baxt B. Molecular basis of pathogenesis of FMDV.
Virus Res. 2003;91:9–32.
9. Robertson BH, Grubman MJ, Weddell GN, Moore DM, Welsh JD, Fischer T,
Dowbenko DJ, Yansura DG, Small B, Kleid DG. Nucleotide and amino acid
sequence coding for polypeptides of foot-and-mouth disease virus type
A12. J Virol. 1985;54:651–60.
10. Grubman MJ, Baxt B. Translation of foot-and-mouth disease virion RNA and
processing of the primary cleavage products in a rabbit reticulocyte lysate.
Virology. 1982;116:19–30.
11. Klump W, Marquardt O, Hofschneider PH. Biologically active protease of
foot and mouth disease virus is expressed from cloned viral cDNA in
Escherichia coli. Proc Natl Acad Sci U S A. 1984;81:3351–5.
12. Acharya R, Fry E, Stuart D, Fox G, Rowlands D, Brown F. The three-
dimensional structure of foot-and-mouth disease virus at 2.9 A resolution.
Nature. 1989;337:709–16.
13. Fry EE, Newman JW, Curry S, Najjam S, Jackson T, Blakemore W, Lea SM,
Miller L, Burman A, King AM, Stuart DI. Structure of Foot-and-mouth disease
virus serotype A10 61 alone and complexed with oligosaccharide receptor:
receptor conservation in the face of antigenic variation. J Gen Virol. 2005;86:
1909–20.
14. Fry EE, Stuart DI, Rowlands DJ. The structure of foot-and-mouth disease
virus. Curr Top Microbiol Immunol. 2005;288:71–101.
15. Han SC, Guo HC, Sun SQ. Three-dimensional structure of foot-and-mouth
disease virus and its biological functions. Arch Virol. 2015;160:1–16.
16. Belsham GJ. Translation and replication of FMDV RNA. Curr Top Microbiol
Immunol. 2005;288:43–70.
17. Zibert A, Maass G, Strebel K, Falk MM, Beck E. Infectious foot-and-mouth
disease virus derived from a cloned full-length cDNA. J Virol. 1990;64:2467–73.
18. Carrillo C, Tulman ER, Delhon G, Lu Z, Carreno A, Vagnozzi A, Kutish GF,
Rock DL. High throughput sequencing and comparative genomics of
foot-and-mouth disease virus. Dev Biol (Basel). 2006;126:23–30.
discussion 323.
19. Carrillo C, Tulman ER, Delhon G, Lu Z, Carreno A, Vagnozzi A, Kutish GF, Rock
DL. Comparative genomics of foot-and-mouth disease virus. J Virol. 2005;79:
6487–504.
20. Mason PW, Bezborodova SV, Henry TM. Identification and characterization
of a cis-acting replication element (cre) adjacent to the internal ribosome
entry site of foot-and-mouth disease virus. J Virol. 2002;76:9686–94.
21. Gerber K, Wimmer E, Paul AV. Biochemical and genetic studies of the
initiation of human rhinovirus 2 RNA replication: identification of a cis-
replicating element in the coding sequence of 2A(pro). J Virol. 2001;75:
10979–90.
22. Paul AV, Rieder E, Kim DW, van Boom JH, Wimmer E. Identification of an
RNA hairpin in poliovirus RNA that serves as the primary template in the in
vitro uridylylation of VPg. J Virol. 2000;74:10359–70.
23. Tiley L, King AM, Belsham GJ. The foot-and-mouth disease virus cis-acting
replication element (cre) can be complemented in trans within infected
cells. J Virol. 2003;77:2243–6.
24. Garcia-Nunez S, Gismondi MI, Konig G, Berinstein A, Taboga O, Rieder E,
Martinez-Salas E, Carrillo E. Enhanced IRES activity by the 3'UTR element
determines the virulence of FMDV isolates. Virology. 2014;448:303–13.
25. Kuhn R, Luz N, Beck E. Functional analysis of the internal translation
initiation site of foot-and-mouth disease virus. J Virol. 1990;64:4625–31.
26. Fajardo Jr T, Rosas MF, Sobrino F, Martinez-Salas E. Exploring IRES region
accessibility by interference of foot-and-mouth disease virus infectivity. PLoS
One. 2012;7:e41382.
27. Lopez de Quinto S, Saiz M, de la Morena D, Sobrino F, Martinez-Salas E.
IRES-driven translation is stimulated separately by the FMDV 3'-NCR and
poly(A) sequences. Nucleic Acids Res. 2002;30:4398–405.
28. Fernandez N, Fernandez-Miragall O, Ramajo J, Garcia-Sacristan A, Bellora N,
Eyras E, Briones C, Martinez-Salas E. Structural basis for the biological relevance
of the invariant apical stem in IRES-mediated translation. Nucleic Acids Res.
2011;39:8572–85.
29. Robertson ME, Seamons RA, Belsham GJ. A selection system for functional
internal ribosome entry site (IRES) elements: analysis of the requirement for
a conserved GNRA tetraloop in the encephalomyocarditis virus IRES. RNA.
1999;5:1167–79.
30. Fernandez N, Buddrus L, Pineiro D, Martinez-Salas E. Evolutionary conserved
motifs constrain the RNA structure organization of picornavirus IRES. FEBS
Lett. 2013;587:1353–8.
31. Fernandez-Miragall O, Martinez-Salas E. Structural organization of a viral IRES
depends on the integrity of the GNRA motif. RNA. 2003;9:1333–44.
32. Saleh L, Rust RC, Fullkrug R, Beck E, Bassili G, Ochs K, Niepmann M. Functional
interaction of translation initiation factor eIF4G with the foot-and-mouth
disease virus internal ribosome entry site. J Gen Virol. 2001;82:757–63.
33. de Breyne S, Yu Y, Unbehaun A, Pestova TV, Hellen CU. Direct functional
interaction of initiation factor eIF4G with type 1 internal ribosomal entry
sites. Proc Natl Acad Sci U S A. 2009;106:9197–202.
34. Pilipenko EV, Gmyl AP, Maslova SV, Svitkin YV, Sinyakov AN, Agol VI.
Prokaryotic-like cis elements in the cap-independent internal initiation of
translation on picornavirus RNA. Cell. 1992;68:119–31.
35. Martinez-Salas E. The impact of RNA structure on picornavirus IRES activity.
Trends Microbiol. 2008;16:230–7.
36. Belsham GJ, Brangwyn JK. A region of the 5' noncoding region of foot-and-
mouth disease virus RNA directs efficient internal initiation of protein
synthesis within cells: involvement with the role of L protease in
translational control. J Virol. 1990;64:5389–95.
37. Lozano G, Fernandez N, Martinez-Salas E. Modeling Three-Dimensional
Structural Motifs of Viral IRES. J Mol Biol. 2016;428:767–76.
38. Sonenberg N, Hinnebusch AG. Regulation of translation initiation in
eukaryotes: mechanisms and biological targets. Cell. 2009;136:731–45.
39. Lopez-Lastra M, Ramdohr P, Letelier A, Vallejos M, Vera-Otarola J, Valiente-
Echeverria F. Translation initiation of viral mRNAs. Rev Med Virol. 2010;20:177–95.
40. Plank TD, Kieft JS. The structures of nonprotein-coding RNAs that drive internal
ribosome entry site function. Wiley Interdiscip Rev RNA. 2012;3:195–212.
41. Stassinopoulos IA, Belsham GJ. A novel protein-RNA binding assay:
functional interactions of the foot-and-mouth disease virus internal
ribosome entry site with cellular proteins. RNA. 2001;7:114–22.
42. Yu Y, Abaeva IS, Marintchev A, Pestova TV, Hellen CU. Common
conformational changes induced in type 2 picornavirus IRESs by cognate
trans-acting factors. Nucleic Acids Res. 2011;39:4851–65.
43. Martinez-Salas E, Francisco-Velilla R, Fernandez-Chamorro J, Lozano G, Diaz-
Toledano R. Picornavirus IRES elements: RNA structure and host protein
interactions. Virus Res. 2015;206:62–73.
44. Lopez de Quinto S, Martinez-Salas E. Interaction of the eIF4G initiation
factor with the aphthovirus IRES is essential for internal translation initiation
in vivo. RNA. 2000;6:1380–92.
45. Lopez de Quinto S, Lafuente E, Martinez-Salas E. IRES interaction with
translation initiation factors: functional characterization of novel RNA
contacts with eIF3, eIF4B, and eIF4GII. RNA. 2001;7:1213–26.
46. Lozano G, Martinez-Salas E. Structural insights into viral IRES-dependent
translation mechanisms. Curr Opin Virol. 2015;12:113–20.
47. Luz N, Beck E. Interaction of a cellular 57-kilodalton protein with the internal
translation initiation site of foot-and-mouth disease virus. J Virol. 1991;65:
6486–94.
48. Luz N, Beck E. A cellular 57 kDa protein binds to two regions of the internal
translation initiation site of foot-and-mouth disease virus. FEBS Lett. 1990;
269:311–4.
49. Walter BL, Nguyen JH, Ehrenfeld E, Semler BL. Differential utilization of
poly(rC) binding protein 2 in translation directed by picornavirus IRES
elements. RNA. 1999;5:1570–85.
50. Bedard KM, Daijogo S, Semler BL. A nucleo-cytoplasmic SR protein functions
in viral IRES-mediated translation initiation. EMBO J. 2007;26:459–67.
51. Pilipenko EV, Pestova TV, Kolupaeva VG, Khitrina EV, Poperechnaya AN, Agol
VI, Hellen CU. A cell cycle-dependent protein serves as a template-specific
translation initiation factor. Genes Dev. 2000;14:2028–45.
52. Pineiro D, Fernandez N, Ramajo J, Martinez-Salas E. Gemin5 promotes IRES
interaction and translation control through its C-terminal region. Nucleic
Acids Res. 2013;41:1017–28.
53. Lin JY, Li ML, Shih SR. Far upstream element binding protein 2 interacts
with enterovirus 71 internal ribosomal entry site and negatively regulates
viral translation. Nucleic Acids Res. 2009;37:47–59.
54. Merrill MK, Gromeier M. The double-stranded RNA binding protein 76:NF45
heterodimer inhibits translation initiation at the rhinovirus type 2 internal
ribosome entry site. J Virol. 2006;80:6936–42.
55. Francisco-Velilla R, Fernandez-Chamorro J, Lozano G, Diaz-Toledano R,
Martinez-Salas E. RNA-protein interaction methods to study viral IRES
elements. Methods. 2015;91:3–12.
Gao et al. Virology Journal  (2016) 13:107 Page 13 of 17
56. Andreev DE, Hirnet J, Terenin IM, Dmitriev SE, Niepmann M, Shatsky IN.
Glycyl-tRNA synthetase specifically binds to the poliovirus IRES to activate
translation initiation. Nucleic Acids Res. 2012;40:5602–14.
57. Serrano P, Pulido MR, Saiz M, Martinez-Salas E. The 3' end of the foot-and-
mouth disease virus genome establishes two distinct long-range RNA-RNA
interactions with the 5' end region. J Gen Virol. 2006;87:3013–22.
58. Saiz M, Gomez S, Martinez-Salas E, Sobrino F. Deletion or substitution of the
aphthovirus 3' NCR abrogates infectivity and virus replication. J Gen Virol.
2001;82:93–101.
59. Rueckert RR, Wimmer E. Systematic nomenclature of picornavirus proteins. J
Virol. 1984;50:957–9.
60. Clarke BE, Sangar DV, Burroughs JN, Newton SE, Carroll AR, Rowlands DJ.
Two initiation sites for foot-and-mouth disease virus polyprotein in vivo. J
Gen Virol. 1985;66(Pt 12):2615–26.
61. Medina M, Domingo E, Brangwyn JK, Belsham GJ. The two species of the
foot-and-mouth disease virus leader protein, expressed individually, exhibit
the same activities. Virology. 1993;194:355–9.
62. Cao X, Bergmann IE, Fullkrug R, Beck E. Functional analysis of the two
alternative translation initiation sites of foot-and-mouth disease virus. J Virol.
1995;69:560–3.
63. Piccone ME, Rieder E, Mason PW, Grubman MJ. The foot-and-mouth disease
virus leader proteinase gene is not required for viral replication. J Virol.
1995;69:5376–82.
64. Lopez de Quinto S, Martinez-Salas E. Involvement of the aphthovirus RNA
region located between the two functional AUGs in start codon selection.
Virology. 1999;255:324–36.
65. Roberts PJ, Belsham GJ. Identification of critical amino acids within the foot-
and-mouth disease virus leader protein, a cysteine protease. Virology. 1995;
213:140–6.
66. Guarne A, Tormo J, Kirchweger R, Pfistermueller D, Fita I, Skern T. Structure of
the foot-and-mouth disease virus leader protease: a papain-like fold adapted
for self-processing and eIF4G recognition. EMBO J. 1998;17:7469–79.
67. Piccone ME, Zellner M, Kumosinski TF, Mason PW, Grubman MJ. Identification
of the active-site residues of the L proteinase of foot-and-mouth disease virus.
J Virol. 1995;69:4950–6.
68. Strebel K, Beck E. A second protease of foot-and-mouth disease virus. J
Virol. 1986;58:893–9.
69. Mason PW, Piccone ME, McKenna TS, Chinsangaram J, Grubman MJ.
Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine
candidate. Virology. 1997;227:96–102.
70. Chinsangaram J, Mason PW, Grubman MJ. Protection of swine by live and
inactivated vaccines prepared from a leader proteinase-deficient serotype
A12 foot-and-mouth disease virus. Vaccine. 1998;16:1516–22.
71. Brown CC, Piccone ME, Mason PW, McKenna TS, Grubman MJ. Pathogenesis
of wild-type and leaderless foot-and-mouth disease virus in cattle. J Virol.
1996;70:5638–41.
72. Kirchweger R, Ziegler E, Lamphear BJ, Waters D, Liebig HD, Sommergruber
W, Sobrino F, Hohenadl C, Blaas D, Rhoads RE, et al. Foot-and-mouth
disease virus leader proteinase: purification of the Lb form and
determination of its cleavage site on eIF-4 gamma. J Virol. 1994;68:5677–84.
73. Devaney MA, Vakharia VN, Lloyd RE, Ehrenfeld E, Grubman MJ. Leader
protein of foot-and-mouth disease virus is required for cleavage of the
p220 component of the cap-binding protein complex. J Virol. 1988;62:
4407–9.
74. Etchison D, Milburn SC, Edery I, Sonenberg N, Hershey JW. Inhibition of
HeLa cell protein synthesis following poliovirus infection correlates with the
proteolysis of a 220,000-dalton polypeptide associated with eucaryotic
initiation factor 3 and a cap binding protein complex. J Biol Chem. 1982;
257:14806–10.
75. Chinsangaram J, Koster M, Grubman MJ. Inhibition of L-deleted foot-and-
mouth disease virus replication by alpha/beta interferon involves double-
stranded RNA-dependent protein kinase. J Virol. 2001;75:5498–503.
76. Chinsangaram J, Piccone ME, Grubman MJ. Ability of foot-and-mouth
disease virus to form plaques in cell culture is associated with suppression
of alpha/beta interferon. J Virol. 1999;73:9891–8.
77. Wang D, Fang L, Liu L, Zhong H, Chen Q, Luo R, Liu X, Zhang Z, Chen H,
Xiao S. Foot-and-mouth disease virus (FMDV) leader proteinase negatively
regulates the porcine interferon-lambda1 pathway. Mol Immunol. 2011;49:
407–12.
78. Friedman RM, Grimley P, Baron S. Biological effects of the interferons and
other cytokines. Biotherapy. 1996;8:189–98.
79. Platanias LC. Mechanisms of type-I- and type-II-interferon-mediated
signalling. Nat Rev Immunol. 2005;5:375–86.
80. de los Santos T, Segundo FD, Zhu J, Koster M, Dias CC, Grubman MJ. A
conserved domain in the leader proteinase of foot-and-mouth disease virus is
required for proper subcellular localization and function. J Virol. 2009;83:1800–10.
81. de Los Santos T, de Avila Botton S, Weiblen R, Grubman MJ. The leader
proteinase of foot-and-mouth disease virus inhibits the induction of beta
interferon mRNA and blocks the host innate immune response. J Virol.
2006;80:1906–14.
82. Wang D, Fang L, Luo R, Ye R, Fang Y, Xie L, Chen H, Xiao S. Foot-and-mouth
disease virus leader proteinase inhibits dsRNA-induced type I interferon
transcription by decreasing interferon regulatory factor 3/7 in protein levels.
Biochem Biophys Res Commun. 2010;399:72–8.
83. Wang D, Fang L, Bi J, Chen Q, Cao L, Luo R, Chen H, Xiao S. Foot-and-
mouth disease virus leader proteinase inhibits dsRNA-induced RANTES
transcription in PK-15 cells. Virus Genes. 2011;42:388–93.
84. Barral PM, Morrison JM, Drahos J, Gupta P, Sarkar D, Fisher PB, Racaniello VR.
MDA-5 is cleaved in poliovirus-infected cells. J Virol. 2007;81:3677–84.
85. Wang D, Fang L, Li P, Sun L, Fan J, Zhang Q, Luo R, Liu X, Li K, Chen H, et al.
The leader proteinase of foot-and-mouth disease virus negatively regulates
the type I interferon pathway by acting as a viral deubiquitinase. J Virol.
2011;85:3758–66.
86. Bibeau-Poirier A, Servant MJ. Roles of ubiquitination in pattern-recognition
receptors and type I interferon receptor signaling. Cytokine. 2008;43:359–67.
87. Isaacson MK, Ploegh HL. Ubiquitination, ubiquitin-like modifiers, and
deubiquitination in viral infection. Cell Host Microbe. 2009;5:559–70.
88. Zhu Z, Yang F, Zhang K, Cao W, Jin Y, Wang G, Mao R, Li D, Guo J, Liu X,
Zheng H. Comparative Proteomic Analysis of Wild-Type and SAP Domain
Mutant Foot-and-Mouth Disease Virus-Infected Porcine Cells Identifies the
Ubiquitin-Activating Enzyme UBE1 Required for Virus Replication. J Proteome
Res. 2015;14:4194–206.
89. Hyrskyluoto A, Bruelle C, Lundh SH, Do HT, Kivinen J, Rappou E, Reijonen S,
Waltimo T, Petersen A, Lindholm D, Korhonen L. Ubiquitin-specific protease-
14 reduces cellular aggregates and protects against mutant huntingtin-
induced cell degeneration: involvement of the proteasome and ER stress-
activated kinase IRE1alpha. Hum Mol Genet. 2014;23:5928–39.
90. Lindner HA, Fotouhi-Ardakani N, Lytvyn V, Lachance P, Sulea T, Menard R.
The papain-like protease from the severe acute respiratory syndrome
coronavirus is a deubiquitinating enzyme. J Virol. 2005;79:15199–208.
91. Kim ET, Oh SE, Lee YO, Gibson W, Ahn JH. Cleavage specificity of the UL48
deubiquitinating protease activity of human cytomegalovirus and the
growth of an active-site mutant virus in cultured cells. J Virol. 2009;83:
12046–56.
92. Lindner HA, Lytvyn V, Qi H, Lachance P, Ziomek E, Menard R. Selectivity in
ISG15 and ubiquitin recognition by the SARS coronavirus papain-like
protease. Arch Biochem Biophys. 2007;466:8–14.
93. Foeger N, Glaser W, Skern T. Recognition of eukaryotic initiation factor 4G
isoforms by picornaviral proteinases. J Biol Chem. 2002;277:44300–9.
94. Donnelly ML, Gani D, Flint M, Monaghan S, Ryan MD. The cleavage activities
of aphthovirus and cardiovirus 2A proteins. J Gen Virol. 1997;78(Pt 1):13–21.
95. Donnelly ML, Luke G, Mehrotra A, Li X, Hughes LE, Gani D, Ryan MD.
Analysis of the aphthovirus 2A/2B polyprotein ‘cleavage’ mechanism
indicates not a proteolytic reaction, but a novel translational effect: a
putative ribosomal ‘skip’. J Gen Virol. 2001;82:1013–25.
96. Donnelly ML, Hughes LE, Luke G, Mendoza H, ten Dam E, Gani D, Ryan MD. The
‘cleavage’ activities of foot-and-mouth disease virus 2A site-directed mutants
and naturally occurring ‘2A-like’ sequences. J Gen Virol. 2001;82:1027–41.
97. Sharma P, Yan F, Doronina VA, Escuin-Ordinas H, Ryan MD, Brown JD. 2A
peptides provide distinct solutions to driving stop-carry on translational
recoding. Nucleic Acids Res. 2012;40:3143–51.
98. Gao ZL, Zhou JH, Zhang J, Ding YZ, Liu YS. The silent point mutations at
the cleavage site of 2A/2B have no effect on the self-cleavage activity of 2A
of foot-and-mouth disease virus. Infect Genet Evol. 2014;28:101–6.
99. Ryan MD, Drew J. Foot-and-mouth disease virus 2A oligopeptide mediated
cleavage of an artificial polyprotein. EMBO J. 1994;13:928–33.
100. Ryan MD, Belsham GJ, King AM. Specificity of enzyme-substrate interactions
in foot-and-mouth disease virus polyprotein processing. Virology. 1989;173:
35–45.
101. Ao D, Sun SQ, Guo HC. Topology and biological function of enterovirus
non-structural protein 2B as a member of the viroporin family. Vet Res.
2014;45:87.
Gao et al. Virology Journal  (2016) 13:107 Page 14 of 17
102. Nieva JL, Madan V, Carrasco L. Viroporins: structure and biological functions.
Nat Rev Microbiol. 2012;10:563–74.
103. Ao D, Guo HC, Sun SQ, Sun DH, Fung TS, Wei YQ, Han SC, Yao XP, Cao SZ,
Liu DX, Liu XT. Viroporin Activity of the Foot-and-Mouth Disease Virus Non-
Structural 2B Protein. PLoS One. 2015;10:e0125828.
104. Moffat K, Knox C, Howell G, Clark SJ, Yang H, Belsham GJ, Ryan M, Wileman
T. Inhibition of the secretory pathway by foot-and-mouth disease virus 2BC
protein is reproduced by coexpression of 2B with 2C, and the site of
inhibition is determined by the subcellular location of 2C. J Virol. 2007;81:
1129–39.
105. Moffat K, Howell G, Knox C, Belsham GJ, Monaghan P, Ryan MD, Wileman T.
Effects of foot-and-mouth disease virus nonstructural proteins on the
structure and function of the early secretory pathway: 2BC but not 3A
blocks endoplasmic reticulum-to-Golgi transport. J Virol. 2005;79:4382–95.
106. Giorda KM, Hebert DN. Viroporins customize host cells for efficient viral
propagation. DNA Cell Biol. 2013;32:557–64.
107. Sheppard HM, Verdon D, Brooks AE, Feisst V, Ho YY, Lorenz N, Fan V, Birch
NP, Didsbury A, Dunbar PR. MicroRNA regulation in human CD8+ T cell
subsets–cytokine exposure alone drives miR-146a expression. J Transl Med.
2014;12:292.
108. Scott C, Griffin S. Viroporins: structure, function and potential as antiviral
targets. J Gen Virol. 2015;96:2000–27.
109. Gorbalenya AE, Koonin EV. Viral proteins containing the purine NTP-binding
sequence pattern. Nucleic Acids Res. 1989;17:8413–40.
110. Teterina NL, Gorbalenya AE, Egger D, Bienz K, Rinaudo MS, Ehrenfeld E.
Testing the modularity of the N-terminal amphipathic helix conserved in
picornavirus 2C proteins and hepatitis C NS5A protein. Virology. 2006;344:
453–67.
111. Klein M, Hadaschik D, Zimmermann H, Eggers HJ, Nelsen-Salz B. The
picornavirus replication inhibitors HBB and guanidine in the echovirus-9
system: the significance of viral protein 2C. J Gen Virol. 2000;81:895–901.
112. Bienz K, Egger D, Troxler M, Pasamontes L. Structural organization of
poliovirus RNA replication is mediated by viral proteins of the P2 genomic
region. J Virol. 1990;64:1156–63.
113. Gosert R, Egger D, Bienz K. A cytopathic and a cell culture adapted hepatitis
A virus strain differ in cell killing but not in intracellular membrane
rearrangements. Virology. 2000;266:157–69.
114. Jecht M, Probst C, Gauss-Muller V. Membrane permeability induced by
hepatitis A virus proteins 2B and 2BC and proteolytic processing of HAV
2BC. Virology. 1998;252:218–27.
115. Bolten R, Egger D, Gosert R, Schaub G, Landmann L, Bienz K. Intracellular
localization of poliovirus plus- and minus-strand RNA visualized by strand-
specific fluorescent In situ hybridization. J Virol. 1998;72:8578–85.
116. Troxler M, Egger D, Pfister T, Bienz K. Intracellular localization of poliovirus
RNA by in situ hybridization at the ultrastructural level using single-stranded
riboprobes. Virology. 1992;191:687–97.
117. Tesar M, Berger HG, Marquardt O. Serological probes for some foot-and-
mouth disease virus nonstructural proteins. Virus Genes. 1989;3:29–44.
118. Wang J, Wang Y, Liu J, Ding L, Zhang Q, Li X, Cao H, Tang J, Zheng SJ. A
critical role of N-myc and STAT interactor (Nmi) in foot-and-mouth disease
virus (FMDV) 2C-induced apoptosis. Virus Res. 2012;170:59–65.
119. Echeverri A, Banerjee R, Dasgupta A. Amino-terminal region of poliovirus 2C
protein is sufficient for membrane binding. Virus Res. 1998;54:217–23.
120. Lippincott-Schwartz J. Bidirectional membrane traffic between the
endoplasmic reticulum and Golgi apparatus. Trends Cell Biol.
1993;3:81–8.
121. Schlegel A, Giddings Jr TH, Ladinsky MS, Kirkegaard K. Cellular origin and
ultrastructure of membranes induced during poliovirus infection. J Virol.
1996;70:6576–88.
122. Teterina NL, Gorbalenya AE, Egger D, Bienz K, Ehrenfeld E. Poliovirus 2C
protein determinants of membrane binding and rearrangements in
mammalian cells. J Virol. 1997;71:8962–72.
123. Saunders K, King AM. Guanidine-resistant mutants of aphthovirus induce
the synthesis of an altered nonstructural polypeptide, P34. J Virol. 1982;42:
389–94.
124. Saunders K, King AM, McCahon D, Newman JW, Slade WR, Forss S.
Recombination and oligonucleotide analysis of guanidine-resistant foot-
and-mouth disease virus mutants. J Virol. 1985;56:921–9.
125. Pfister T, Wimmer E. Characterization of the nucleoside triphosphatase
activity of poliovirus protein 2C reveals a mechanism by which guanidine
inhibits poliovirus replication. J Biol Chem. 1999;274:6992–7001.
126. Barton DJ, Flanegan JB. Synchronous replication of poliovirus RNA: initiation
of negative-strand RNA synthesis requires the guanidine-inhibited activity of
protein 2C. J Virol. 1997;71:8482–9.
127. Lubroth J, Brown F. Identification of native foot-and-mouth disease virus
non-structural protein 2C as a serological indicator to differentiate infected
from vaccinated livestock. Res Vet Sci. 1995;59:70–8.
128. Lubroth J, Grubman MJ, Burrage TG, Newman JF, Brown F. Absence of
protein 2C from clarified foot-and-mouth disease virus vaccines provides
the basis for distinguishing convalescent from vaccinated animals. Vaccine.
1996;14:419–27.
129. Lu Z, Zhang X, Fu Y, Cao Y, Tian M, Sun P, Li D, Liu Z, Xie Q. Expression of
the major epitope regions of 2C integrated with the 3AB non-structural
protein of foot-and-mouth disease virus and its potential for differentiating
infected from vaccinated animals. J Virol Methods. 2010;170:128–33.
130. Meyer RF, Babcock GD, Newman JF, Burrage TG, Toohey K, Lubroth J, Brown
F. Baculovirus expressed 2C of foot-and-mouth disease virus has the
potential for differentiating convalescent from vaccinated animals. J Virol
Methods. 1997;65:33–43.
131. Banerjee R, Dasgupta A. Interaction of picornavirus 2C polypeptide with the
viral negative-strand RNA. J Gen Virol. 2001;82:2621–7.
132. Rodriguez PL, Carrasco L. Poliovirus protein 2C contains two regions
involved in RNA binding activity. J Biol Chem. 1995;270:10105–12.
133. Adams P, Kandiah E, Effantin G, Steven AC, Ehrenfeld E. Poliovirus 2C
protein forms homo-oligomeric structures required for ATPase activity. J Biol
Chem. 2009;284:22012–21.
134. Rodriguez PL, Carrasco L. Poliovirus protein 2C has ATPase and GTPase
activities. J Biol Chem. 1993;268:8105–10.
135. Tang WF, Yang SY, Wu BW, Jheng JR, Chen YL, Shih CH, Lin KH, Lai HC,
Tang P, Horng JT. Reticulon 3 binds the 2C protein of enterovirus 71 and is
required for viral replication. J Biol Chem. 2007;282:5888–98.
136. Sweeney TR, Cisnetto V, Bose D, Bailey M, Wilson JR, Zhang X, Belsham GJ,
Curry S. Foot-and-mouth disease virus 2C is a hexameric AAA+ protein with
a coordinated ATP hydrolysis mechanism. J Biol Chem. 2010;285:24347–59.
137. Zheng W, Li X, Wang J, Li X, Cao H, Wang Y, Zeng Q, Zheng SJ. A critical
role of interferon-induced protein IFP35 in the type I interferon response in
cells induced by foot-and-mouth disease virus (FMDV) protein 2C. Arch
Virol. 2014;159:2925–35.
138. Fillmore RA, Mitra A, Xi Y, Ju J, Scammell J, Shevde LA, Samant RS. Nmi (N-
Myc interactor) inhibits Wnt/beta-catenin signaling and retards tumor
growth. Int J Cancer. 2009;125:556–64.
139. Chen J, Naumovski L. Intracellular redistribution of interferon-inducible
proteins Nmi and IFP 35 in apoptotic cells. J Interferon Cytokine Res. 2002;
22:237–43.
140. Zhang L, Tang Y, Tie Y, Tian C, Wang J, Dong Y, Sun Z, He F. The PH
domain containing protein CKIP-1 binds to IFP35 and Nmi and is involved
in cytokine signaling. Cell Signal. 2007;19:932–44.
141. Chen J, Shpall RL, Meyerdierks A, Hagemeier M, Bottger EC, Naumovski L.
Interferon-inducible Myc/STAT-interacting protein Nmi associates with IFP
35 into a high molecular mass complex and inhibits proteasome-mediated
degradation of IFP 35. J Biol Chem. 2000;275:36278–84.
142. Lee ND, Chen J, Shpall RL, Naumovski L. Subcellular localization of interferon-
inducible Myc/stat-interacting protein Nmi is regulated by a novel IFP 35
homologous domain. J Interferon Cytokine Res. 1999;19:1245–52.
143. Zhou X, Liao J, Meyerdierks A, Feng L, Naumovski L, Bottger EC, Omary MB.
Interferon-alpha induces nmi-IFP35 heterodimeric complex formation that is
affected by the phosphorylation of IFP35. J Biol Chem. 2000;275:21364–71.
144. Ku BK, Kim SB, Moon OK, Lee SJ, Lee JH, Lyoo YS, Kim HJ, Sur JH. Role of
apoptosis in the pathogenesis of Asian and South American foot-and-
mouth disease viruses in swine. J Vet Med Sci. 2005;67:1081–8.
145. de Los ST, Diaz-San Segundo F, Grubman MJ. Degradation of nuclear factor
kappa B during foot-and-mouth disease virus infection. J Virol. 2007;81:
12803–15.
146. Diaz-San Segundo F, Salguero FJ, de Avila A, de Marco MM, Sanchez-Martin
MA, Sevilla N. Selective lymphocyte depletion during the early stage of the
immune response to foot-and-mouth disease virus infection in swine. J
Virol. 2006;80:2369–79.
147. O'Donnell V, Pacheco JM, LaRocco M, Burrage T, Jackson W, Rodriguez LL,
Borca MV, Baxt B. Foot-and-mouth disease virus utilizes an autophagic
pathway during viral replication. Virology. 2011;410:142–50.
148. Gannage M, Ramer PC, Munz C. Targeting Beclin 1 for viral subversion of
macroautophagy. Autophagy. 2010;6:166–7.
Gao et al. Virology Journal  (2016) 13:107 Page 15 of 17
149. Kang R, Zeh HJ, Lotze MT, Tang D. The Beclin 1 network regulates
autophagy and apoptosis. Cell Death Differ. 2011;18:571–80.
150. Gladue DP, O'Donnell V, Baker-Branstetter R, Holinka LG, Pacheco JM,
Fernandez-Sainz I, Lu Z, Brocchi E, Baxt B, Piccone ME, et al. Foot-and-
mouth disease virus nonstructural protein 2C interacts with Beclin1,
modulating virus replication. J Virol. 2012;86:12080–90.
151. Knowles NJ, Davies PR, Henry T, O'Donnell V, Pacheco JM, Mason PW.
Emergence in Asia of foot-and-mouth disease viruses with altered host range:
characterization of alterations in the 3A protein. J Virol. 2001;75:1551–6.
152. Garcia-Briones M, Rosas MF, Gonzalez-Magaldi M, Martin-Acebes MA, Sobrino
F, Armas-Portela R. Differential distribution of non-structural proteins of foot-
and-mouth disease virus in BHK-21 cells. Virology. 2006;349:409–21.
153. Rosas MF, Vieira YA, Postigo R, Martin-Acebes MA, Armas-Portela R,
Martinez-Salas E, Sobrino F. Susceptibility to viral infection is enhanced by
stable expression of 3A or 3AB proteins from foot-and-mouth disease virus.
Virology. 2008;380:34–45.
154. Beard CW, Mason PW. Genetic determinants of altered virulence of
Taiwanese foot-and-mouth disease virus. J Virol. 2000;74:987–91.
155. Nunez JI, Baranowski E, Molina N, Ruiz-Jarabo CM, Sanchez C, Domingo E,
Sobrino F. A single amino acid substitution in nonstructural protein 3A can
mediate adaptation of foot-and-mouth disease virus to the guinea pig. J
Virol. 2001;75:3977–83.
156. Harris JR, Racaniello VR. Amino acid changes in proteins 2B and 3A mediate
rhinovirus type 39 growth in mouse cells. J Virol. 2005;79:5363–73.
157. Pacheco JM, Gladue DP, Holinka LG, Arzt J, Bishop E, Smoliga G, Pauszek SJ,
Bracht AJ, O'Donnell V, Fernandez-Sainz I, et al. A partial deletion in non-
structural protein 3A can attenuate foot-and-mouth disease virus in cattle.
Virology. 2013;446:260–7.
158. Giraudo AT, Beck E, Strebel K, de Mello PA, La Torre JL, Scodeller EA, Bergmann
IE. Identification of a nucleotide deletion in parts of polypeptide 3A in two
independent attenuated aphthovirus strains. Virology. 1990;177:780–3.
159. Ma X, Li P, Bai X, Sun P, Bao H, Lu Z, Cao Y, Li D, Chen Y, Qiao Z, Liu Z.
Sequences outside that of residues 93-102 of 3A protein can contribute to
the ability of foot-and-mouth disease virus (FMDV) to replicate in bovine-
derived cells. Virus Res. 2014;191:161–71.
160. De Diego M, Brocchi E, Mackay D, De Simone F. The non-structural polyprotein
3ABC of foot-and-mouth disease virus as a diagnostic antigen in ELISA to
differentiate infected from vaccinated cattle. Arch Virol. 1997;142:2021–33.
161. Brocchi E, Bergmann IE, Dekker A, Paton DJ, Sammin DJ, Greiner M, Grazioli
S, De Simone F, Yadin H, Haas B, et al. Comparative evaluation of six ELISAs
for the detection of antibodies to the non-structural proteins of foot-and-
mouth disease virus. Vaccine. 2006;24:6966–79.
162. Clavijo A, Hole K, Li M, Collignon B. Simultaneous detection of antibodies to
foot-and-mouth disease non-structural proteins 3ABC, 3D, 3A and 3B by a
multiplexed Luminex assay to differentiate infected from vaccinated cattle.
Vaccine. 2006;24:1693–704.
163. Sorensen KJ, de Stricker K, Dyrting KC, Grazioli S, Haas B. Differentiation of
foot-and-mouth disease virus infected animals from vaccinated animals
using a blocking ELISA based on baculovirus expressed FMDV 3ABC antigen
and a 3ABC monoclonal antibody. Arch Virol. 2005;150:805–14.
164. Pacheco JM, Henry TM, O'Donnell VK, Gregory JB, Mason PW. Role of
nonstructural proteins 3A and 3B in host range and pathogenicity of foot-
and-mouth disease virus. J Virol. 2003;77:13017–27.
165. Carrillo C, Lu Z, Borca MV, Vagnozzi A, Kutish GF, Rock DL. Genetic and
phenotypic variation of foot-and-mouth disease virus during serial passages
in a natural host. J Virol. 2007;81:11341–51.
166. Paul AV, Wimmer E. Initiation of protein-primed picornavirus RNA synthesis.
Virus Res. 2015;206:12–26.
167. Nayak A, Goodfellow IG, Belsham GJ. Factors required for the Uridylylation
of the foot-and-mouth disease virus 3B1, 3B2, and 3B3 peptides by the
RNA-dependent RNA polymerase (3Dpol) in vitro. J Virol. 2005;79:7698–706.
168. Nayak A, Goodfellow IG, Woolaway KE, Birtley J, Curry S, Belsham GJ. Role
of RNA structure and RNA binding activity of foot-and-mouth disease
virus 3C protein in VPg uridylylation and virus replication. J Virol. 2006;80:
9865–75.
169. Falk MM, Sobrino F, Beck E. VPg gene amplification correlates with infective
particle formation in foot-and-mouth disease virus. J Virol. 1992;66:2251–60.
170. Pacheco JM, Piccone ME, Rieder E, Pauszek SJ, Borca MV, Rodriguez LL.
Domain disruptions of individual 3B proteins of foot-and-mouth disease
virus do not alter growth in cell culture or virulence in cattle. Virology. 2010;
405:149–56.
171. Birtley JR, Knox SR, Jaulent AM, Brick P, Leatherbarrow RJ, Curry S. Crystal
structure of foot-and-mouth disease virus 3C protease. New insights into
catalytic mechanism and cleavage specificity. J Biol Chem. 2005;280:11520–7.
172. Grubman MJ, Zellner M, Bablanian G, Mason PW, Piccone ME. Identification
of the active-site residues of the 3C proteinase of foot-and-mouth disease
virus. Virology. 1995;213:581–9.
173. Zunszain PA, Knox SR, Sweeney TR, Yang J, Roque-Rosell N, Belsham GJ,
Leatherbarrow RJ, Curry S. Insights into cleavage specificity from the crystal
structure of foot-and-mouth disease virus 3C protease complexed with a
peptide substrate. J Mol Biol. 2010;395:375–89.
174. Sweeney TR, Roque-Rosell N, Birtley JR, Leatherbarrow RJ, Curry S. Structural
and mutagenic analysis of foot-and-mouth disease virus 3C protease reveals
the role of the beta-ribbon in proteolysis. J Virol. 2007;81:115–24.
175. Bablanian GM, Grubman MJ. Characterization of the foot-and-mouth disease
virus 3C protease expressed in Escherichia coli. Virology. 1993;197:320–7.
176. Palmenberg AC. Proteolytic processing of picornaviral polyprotein. Annu
Rev Microbiol. 1990;44:603–23.
177. Ypma-Wong MF, Dewalt PG, Johnson VH, Lamb JG, Semler BL. Protein 3CD
is the major poliovirus proteinase responsible for cleavage of the P1 capsid
precursor. Virology. 1988;166:265–70.
178. Belsham GJ, McInerney GM, Ross-Smith N. Foot-and-mouth disease virus 3C
protease induces cleavage of translation initiation factors eIF4A and eIF4G
within infected cells. J Virol. 2000;74:272–80.
179. Henikoff S. Nucleosome destabilization in the epigenetic regulation of gene
expression. Nat Rev Genet. 2008;9:15–26.
180. Tesar M, Marquardt O. Foot-and-mouth disease virus protease 3C inhibits cellular
transcription and mediates cleavage of histone H3. Virology. 1990;174:364–74.
181. Lawrence P, Schafer EA, Rieder E. The nuclear protein Sam68 is cleaved by
the FMDV 3C protease redistributing Sam68 to the cytoplasm during FMDV
infection of host cells. Virology. 2012;425:40–52.
182. Wang D, Fang L, Li K, Zhong H, Fan J, Ouyang C, Zhang H, Duan E, Luo R,
Zhang Z, et al. Foot-and-mouth disease virus 3C protease cleaves NEMO to
impair innate immune signaling. J Virol. 2012;86:9311–22.
183. Zhao T, Yang L, Sun Q, Arguello M, Ballard DW, Hiscott J, Lin R. The NEMO
adaptor bridges the nuclear factor-kappaB and interferon regulatory factor
signaling pathways. Nat Immunol. 2007;8:592–600.
184. Yang F, Yamashita J, Tang E, Wang HL, Guan K, Wang CY. The zinc finger
mutation C417R of I-kappa B kinase gamma impairs lipopolysaccharide-
and TNF-mediated NF-kappa B activation through inhibiting
phosphorylation of the I-kappa B kinase beta activation loop. J Immunol.
2004;172:2446–52.
185. Robertson BH, Morgan DO, Moore DM, Grubman MJ, Card J, Fischer T,
Weddell G, Dowbenko D, Yansura D. Identification of amino acid and
nucleotide sequence of the foot-and-mouth disease virus RNA polymerase.
Virology. 1983;126:614–23.
186. George M, Venkataramanan R, Pattnaik B, Sanyal A, Gurumurthy CB,
Hemadri D, Tosh C. Sequence analysis of the RNA polymerase gene of foot-
and-mouth disease virus serotype Asia1. Virus Genes. 2001;22:21–6.
187. Ferrer-Orta C, Arias A, Escarmis C, Verdaguer N. A comparison of viral RNA-
dependent RNA polymerases. Curr Opin Struct Biol. 2006;16:27–34.
188. Ferrer-Orta C, Arias A, Perez-Luque R, Escarmis C, Domingo E, Verdaguer
N. Structure of foot-and-mouth disease virus RNA-dependent RNA
polymerase and its complex with a template-primer RNA. J Biol Chem.
2004;279:47212–21.
189. van Dijk AA, Makeyev EV, Bamford DH. Initiation of viral RNA-dependent
RNA polymerization. J Gen Virol. 2004;85:1077–93.
190. Ferrer-Orta C, Arias A, Agudo R, Perez-Luque R, Escarmis C, Domingo E,
Verdaguer N. The structure of a protein primer-polymerase complex in the
initiation of genome replication. EMBO J. 2006;25:880–8.
191. Ferrer-Orta C, Ferrero D, Verdaguer N. RNA-Dependent RNA Polymerases of
Picornaviruses: From the Structure to Regulatory Mechanisms. Viruses. 2015;
7:4438–60.
192. Gruez A, Selisko B, Roberts M, Bricogne G, Bussetta C, Jabafi I, Coutard B, De
Palma AM, Neyts J, Canard B. The crystal structure of coxsackievirus B3 RNA-
dependent RNA polymerase in complex with its protein primer VPg
confirms the existence of a second VPg binding site on Picornaviridae
polymerases. J Virol. 2008;82:9577–90.
193. Chen C, Wang Y, Shan C, Sun Y, Xu P, Zhou H, Yang C, Shi PY, Rao Z, Zhang
B, Lou Z. Crystal structure of enterovirus 71 RNA-dependent RNA
polymerase complexed with its protein primer VPg: implication for a trans
mechanism of VPg uridylylation. J Virol. 2013;87:5755–68.
Gao et al. Virology Journal  (2016) 13:107 Page 16 of 17
194. Sierra S, Davila M, Lowenstein PR, Domingo E. Response of foot-and-mouth
disease virus to increased mutagenesis: influence of viral load and fitness in
loss of infectivity. J Virol. 2000;74:8316–23.
195. Graci JD, Cameron CE. Quasispecies, error catastrophe, and the antiviral
activity of ribavirin. Virology. 2002;298:175–80.
196. Airaksinen A, Pariente N, Menendez-Arias L, Domingo E. Curing of foot-and-
mouth disease virus from persistently infected cells by ribavirin involves
enhanced mutagenesis. Virology. 2003;311:339–49.
197. Kumar R, Hosamani M, Sreenivasa BP, Kotyal A, Venkataramanan R.
Expression of Foot-and-Mouth Disease Virus Non-Structural Protein, 3D in
Insect Cells and its Application in Detection of Anti-FMDV Antibodies.
Indian J Virol. 2012;23:326–32.
198. Almeida MR, Rieder E, Chinsangaram J, Ward G, Beard C, Grubman MJ,
Mason PW. Construction and evaluation of an attenuated vaccine for foot-
and-mouth disease: difficulty adapting the leader proteinase-deleted
strategy to the serotype O1 virus. Virus Res. 1998;55:49–60.
199. Rodriguez-Calvo T, Diaz-San Segundo F, Sanz-Ramos M, Sevilla N. A
replication analysis of foot-and-mouth disease virus in swine lymphoid
tissue might indicate a putative carrier stage in pigs. Vet Res. 2011;42:22.
200. Horsington J, Zhang Z. Analysis of foot-and-mouth disease virus replication
using strand-specific quantitative RT-PCR. J Virol Methods. 2007;144:149–55.
201. He C, Wang H, Wei H, Yan Y, Zhao T, Hu X, Luo P, Wang L, Yu Y. A
recombinant truncated FMDV 3AB protein used to better distinguish
between infected and vaccinated cattle. Vaccine. 2010;28:3435–9.
202. Nogueira Santos JA, Assis DM, Gouvea IE, Judice WA, Izidoro MA, Juliano
MA, Skern T, Juliano L. Foot and mouth disease leader protease (Lbpro):
Investigation of prime side specificity allows the synthesis of a potent
inhibitor. Biochimie. 2012;94:711–8.
203. Guo C, Zhang C, Zheng H, Huang Y. Recombinant adenovirus expression of
FMDV P1-2A and 3C protein and its immune response in mice. Res Vet Sci.
2013;95:736–41.
204. Dory D, Remond M, Beven V, Cariolet R, Zientara S, Jestin A. Foot-and-
Mouth Disease Virus neutralizing antibodies production induced by
pcDNA3 and Sindbis virus based plasmid encoding FMDV P1-2A3C3D in
swine. Antiviral Res. 2009;83:45–52.
205. Chang Y, Dou Y, Bao H, Luo X, Liu X, Mu K, Liu Z, Liu X, Cai X. Multiple
microRNAs targeted to internal ribosome entry site against foot-and-mouth
disease virus infection in vitro and in vivo. Virol J. 2014;11:1.
206. Han SC, Guo HC, Sun SQ, Jin Y, Wei YQ, Feng X, Yao XP, Cao SZ, Xiang Liu
D, Liu XT. Productive Entry of Foot-and-Mouth Disease Virus via
Macropinocytosis Independent of Phosphatidylinositol 3-Kinase. Sci Rep.
2016;6:19294.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Gao et al. Virology Journal  (2016) 13:107 Page 17 of 17
